Kidney Cancer Highlights

The surgical and medical treatment of renal cell carcinoma (RCC) has
changed dramatically in the last several years and continues to constantly
evolve. This kidney cancer webcast series intends to educate the
audience regarding the management of the complete spectrum of kidney
cancer patients; from small renal masses through metastatic disease. 
The talks included in the webcast will elucidate the established principles
to guide treatment decisions in this group of patients as well as newer
data and areas of disagreement and controversy. It is our hope that you
will find this session informative and up to date regarding all aspects of kidney cancer management.

	Current Role of Cytoreductive Nephrectomy
	Estimated Time: 45 minutes Release Date: 01/21/09 Type: Webcast	Technical Requirements: Windows Media Expiration Date: 01/21/10 Specialties: Nephrology, Urology, Oncology
	Initial Systemic Therapy Options
	Estimated Time: 1 hour Release Date: 01/21/09 Type: Webcast	Technical Requirements: Windows Media Expiration Date: 01/21/10 Specialties: Nephrology, Urology, Oncology
	Management of Small Renal Masses: The Role of Percutaneous Biopsy
	Estimated Time: 45 minutes Release Date: 01/21/09 Type: Webcast	Technical Requirements: Windows Media Expiration Date: 01/21/10 Specialties: Nephrology, Urology, Oncology
	Management of Small Renal Masses: What is the Best Management Option in this Case?
	Estimated Time: 1 hour Release Date: 01/21/09 Type: Webcast	Technical Requirements: Windows Media Expiration Date: 01/21/10 Specialties: Nephrology, Urology, Oncology

Series Objectives

On completion of this educational series, participants will be able to:

1. Review the biology of renal cell carcinoma.
2. Discuss the role of renal biopsy.
3. Discuss various management options for small renal masses.
4. Describe the current systemic treatment options in metastatic renal cell carcinoma.